๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ischemic preconditioning in deceased donor liver transplantation: A prospective randomized clinical trial of safety and efficacy

โœ Scribed by Baburao Koneru; Adrian Fisher; Yan He; Kenneth M. Klein; Joan Skurnick; Dorian J. Wilson; Andrew N. de la Torre; Anand Merchant; Rakesh Arora; Arun K. Samanta


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
92 KB
Volume
11
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Global gene expression profiles of ische
โœ Ali Raza; George Dikdan; Kunj K. Desai; Asif Shareef; Helen Fernandes; Virginie ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 326 KB ๐Ÿ‘ 1 views

The benefits of ischemic preconditioning (IPC) in reducing ischemia/reperfusion injury (IRI) remain indistinct in human liver transplantation (LT). To further understand mechanistic aspects of IPC, we performed microarray analyses as a nested substudy in a randomized trial of 10-minute IPC in 101 de

Effect of ischemic preconditioning in wh
โœ Matteo Cescon; Gian Luca Grazi; Alberto Grassi; Matteo Ravaioli; Gaetano Vetrone ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 162 KB ๐Ÿ‘ 1 views

The effect of ischemic preconditioning (IPC) in orthotopic liver transplantation (OLT) has not yet been clarified. We performed a pilot study to evaluate the effects of IPC in OLT by comparing the outcomes of recipients of grafts from deceased donors randomly assigned to receive (IPCฯฉ group, n ฯญ 23)

Effect of ischemic preconditioning on th
โœ Wayel Jassem; Susan Fuggle; Richard Thompson; Matthew Arno; Jennifer Taylor; Jan ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 180 KB ๐Ÿ‘ 1 views

Ischemic preconditioning (IP) is an effective method for protecting organs from ischemia/reperfusion (IR) injury; however, the molecular basis of this protective effect is poorly understood. This study assessed the gene expression profile in liver allografts during transplantation and evaluated the

A prospective, randomized, double-blind
โœ Fleckenstein, Jaquelyn F. ;Paredes, Melinda ;Thuluvath, Paul J. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 68 KB

Acute cellular rejection (ACR) after orthotopic liver transplantation occurs in 50% to 80% of patients despite the recent advances in immunosuppressive therapy. Adjuvant use of ursodeoxycholic acid (UDCA) is theoretically attractive, but studies have shown conflicting results. In this randomized, co

Early cyclosporine monotherapy in liver
โœ Luca S. Belli; Luciano de Carlis; Gianfranco Rondinara; Alberto B. Alberti; Gior ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 89 KB ๐Ÿ‘ 2 views

Maintenance of adequate immunosuppression and avoidance of side-effects are the goals of long-term management of all organ-transplanted patients. We here report the final results of a prospective, randomized trial comparing early cyclosporine monotherapy versus double-drug therapy (cyclosporine and